SEC Company Response from ORAGENICS INC (OGEN) (CIK 0001174940) (OGEN) — Dec 20, 2011
ORAGENICS INC (OGEN) (CIK 0001174940)
Date: Dec. 20, 2011 · CIK: 0001174940 · Accession: 0001193125-11-346502
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-32188
Referenced dates: December 13, 2011
Letter
Via Edgar United States Securities and Exchange Commission Re: Oragenics, Inc. Form 10-K for Fiscal year ended December 31, 2010 File No. 001-32188
Dear Mr. Riedler:
Set forth below are responses to the Staff of the Division of Corporation Finance’s comment letter dated December 13, 2011, with respect to Oragenics’ Form 10-K (001-32188). For your convenience, the Staff’s comments are set forth in bold and followed by the Company’s response.
Comments
1. We note your response to prior comment 1. Please provide an expanded legal analysis as to why your promissory note with KFLP would not be considered payment for property or services such that Christine Koski and Robert Koski would not be considered independent directors under NASDAQ Marketplace Rule 5605(a)(2)(D).
Response:
The Company previously stated in its prior response to the Staff that it believed that payments under the promissory note would not constitute payment by the Company for property or services under NASDAQ Marketplace Rule 5605(a)(2)(D). This statement was based on the exception under subsection (i) of such Marketplace Rule for “(i) payments arising solely from investments in the Company’s securities;”.
Jeffrey Riedler
Securities and Exchange Commission
December 15, 2011
Page 2
The Company believes the issuance by the Company of the promissory note to the KFLP is part of an investment by the KFLP in debt securities of the Company and since any payments associated or connected therewith would arise solely from such investment, the Company believes that it falls within the exception from not being considered payment for property or services provided by 5605(a)(2)(D)(i) noted above.
* * * * *
As requested, the Company acknowledges the following:
The Company is responsible for the adequacy and accuracy of the disclosure in the filing;
That staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and
The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should you have any questions or clarifications of the matters raised in this letter please contact me at (813) 286-7900.
Sincerely,
/s/ Brian J. Bohunicky
Show Raw Text
CORRESP 1 filename1.htm Correspondence BRIAN J. BOHUNICKY (813) 286-7900 bbohunicky@oragenics.com December 20, 2011 Via Edgar Jeffrey Riedler, Division of Corporation Finance United States Securities and Exchange Commission 100 F Street Washington, DC 20549 Re: Oragenics, Inc. Form 10-K for Fiscal year ended December 31, 2010 File No. 001-32188 Dear Mr. Riedler: Set forth below are responses to the Staff of the Division of Corporation Finance’s comment letter dated December 13, 2011, with respect to Oragenics’ Form 10-K (001-32188). For your convenience, the Staff’s comments are set forth in bold and followed by the Company’s response. Comments 1. We note your response to prior comment 1. Please provide an expanded legal analysis as to why your promissory note with KFLP would not be considered payment for property or services such that Christine Koski and Robert Koski would not be considered independent directors under NASDAQ Marketplace Rule 5605(a)(2)(D). Response: The Company previously stated in its prior response to the Staff that it believed that payments under the promissory note would not constitute payment by the Company for property or services under NASDAQ Marketplace Rule 5605(a)(2)(D). This statement was based on the exception under subsection (i) of such Marketplace Rule for “(i) payments arising solely from investments in the Company’s securities;”. Jeffrey Riedler Securities and Exchange Commission December 15, 2011 Page 2 The Company believes the issuance by the Company of the promissory note to the KFLP is part of an investment by the KFLP in debt securities of the Company and since any payments associated or connected therewith would arise solely from such investment, the Company believes that it falls within the exception from not being considered payment for property or services provided by 5605(a)(2)(D)(i) noted above. * * * * * As requested, the Company acknowledges the following: The Company is responsible for the adequacy and accuracy of the disclosure in the filing; That staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Should you have any questions or clarifications of the matters raised in this letter please contact me at (813) 286-7900. Sincerely, /s/ Brian J. Bohunicky Brian J. Bohunicky, Chief Financial Officer